HK1086775A1 - Uses of fluorinated triazoles for treating affective or attention disorders - Google Patents

Uses of fluorinated triazoles for treating affective or attention disorders

Info

Publication number
HK1086775A1
HK1086775A1 HK06106764.5A HK06106764A HK1086775A1 HK 1086775 A1 HK1086775 A1 HK 1086775A1 HK 06106764 A HK06106764 A HK 06106764A HK 1086775 A1 HK1086775 A1 HK 1086775A1
Authority
HK
Hong Kong
Prior art keywords
attention disorders
treating affective
triazoles
fluorinated
fluorinated triazoles
Prior art date
Application number
HK06106764.5A
Other languages
English (en)
Inventor
Markus Schmutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/259,911 external-priority patent/US6054471A/en
Priority claimed from US09/259,910 external-priority patent/US6156775A/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1086775A1 publication Critical patent/HK1086775A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK06106764.5A 1999-03-01 2006-06-13 Uses of fluorinated triazoles for treating affective or attention disorders HK1086775A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/259,911 US6054471A (en) 1999-03-01 1999-03-01 Use of fluorinated triazoles in treating neuropathic pain
US09/259,910 US6156775A (en) 1999-03-01 1999-03-01 Use of fluorinated triazoles in treating affective and attention disorders

Publications (1)

Publication Number Publication Date
HK1086775A1 true HK1086775A1 (en) 2006-09-29

Family

ID=26947613

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106764.5A HK1086775A1 (en) 1999-03-01 2006-06-13 Uses of fluorinated triazoles for treating affective or attention disorders

Country Status (25)

Country Link
EP (2) EP1609505B1 (xx)
JP (1) JP4700195B2 (xx)
KR (2) KR100839765B1 (xx)
CN (2) CN1636562A (xx)
AT (1) ATE303179T1 (xx)
AU (1) AU764508B2 (xx)
BR (1) BR0008606A (xx)
CA (1) CA2362411C (xx)
CY (1) CY1115241T1 (xx)
DE (1) DE60022317T2 (xx)
DK (2) DK1156856T3 (xx)
ES (2) ES2441208T3 (xx)
HK (1) HK1086775A1 (xx)
HU (2) HU227602B1 (xx)
ID (1) ID29891A (xx)
IL (3) IL144852A0 (xx)
NO (2) NO328927B1 (xx)
NZ (1) NZ513716A (xx)
PL (2) PL199660B1 (xx)
PT (1) PT1609505E (xx)
RU (1) RU2238725C2 (xx)
SI (1) SI1609505T1 (xx)
SK (2) SK286775B6 (xx)
TW (1) TW513301B (xx)
WO (1) WO2000051577A2 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2905878T3 (es) 2015-01-30 2022-04-12 Neurocrine Biosciences Inc Triazoles sustituidos y métodos relacionados con los mismos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1511195A (en) * 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
FI93544C (fi) * 1985-04-18 1995-04-25 Ciba Geigy Ag Menetelmä fluorattujen, antikonvulsiivisesti vaikuttavien 1-bentsyyli-1H-1,2,3-triatsoliyhdisteiden valmistamiseksi

Also Published As

Publication number Publication date
HU1000576D0 (en) 2010-12-28
EP1609505A1 (en) 2005-12-28
HU230044B1 (hu) 2015-05-28
PL199660B1 (pl) 2008-10-31
NO20014180D0 (no) 2001-08-28
CA2362411C (en) 2009-11-24
RU2238725C2 (ru) 2004-10-27
AU3425300A (en) 2000-09-21
JP2002538100A (ja) 2002-11-12
CN1636562A (zh) 2005-07-13
KR20080003944A (ko) 2008-01-08
KR100839766B1 (ko) 2008-06-20
SI1609505T1 (sl) 2014-03-31
SK286775B6 (sk) 2009-05-07
KR100839765B1 (ko) 2008-06-20
SK12252001A3 (sk) 2002-05-09
ID29891A (id) 2001-10-18
DE60022317T2 (de) 2006-06-01
DK1156856T3 (da) 2005-10-31
DK1609505T3 (en) 2014-02-17
KR20010108285A (ko) 2001-12-07
PT1609505E (pt) 2014-02-24
CN1356916A (zh) 2002-07-03
CY1115241T1 (el) 2017-01-04
EP1156856A2 (en) 2001-11-28
TW513301B (en) 2002-12-11
ES2244413T3 (es) 2005-12-16
NO20014180L (no) 2001-08-28
ES2441208T3 (es) 2014-02-03
EP1609505B1 (en) 2013-12-11
HUP0302780A2 (hu) 2003-12-29
AU764508B2 (en) 2003-08-21
NO334104B1 (no) 2013-12-09
JP4700195B2 (ja) 2011-06-15
NO20092921L (no) 2001-08-28
PL197158B1 (pl) 2008-03-31
NZ513716A (en) 2003-10-31
PL350418A1 (en) 2002-12-16
WO2000051577A2 (en) 2000-09-08
HU227602B1 (en) 2011-09-28
ATE303179T1 (de) 2005-09-15
SK286203B6 (sk) 2008-05-06
WO2000051577A3 (en) 2001-01-25
BR0008606A (pt) 2002-01-22
DE60022317D1 (de) 2005-10-06
CA2362411A1 (en) 2000-09-08
IL144852A0 (en) 2002-06-30
NO328927B1 (no) 2010-06-14
HUP0302780A3 (en) 2004-10-28
IL189190A0 (en) 2008-06-05
IL144852A (en) 2008-11-26
EP1156856B1 (en) 2005-08-31
CN1195516C (zh) 2005-04-06

Similar Documents

Publication Publication Date Title
EP1487877A4 (en) COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMORS
ZA200309808B (en) Compositions and methods for the diagnosis and treatment of tumor
PT1955700E (pt) Tratamento terap?utico de doen?as associadas ao receptor de androg?nios
IL139591A0 (en) Combination therapy for treatment of bipolar disorders
EP0892632A4 (en) AGENTS FOR USE IN PHOTOTHERAPEUTIC TREATMENT OF PROLIFERATIVE SKIN DISORDERS
HK1068350A1 (en) Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain
GB9621630D0 (en) Treatment of skin disorders
IL140415A0 (en) The use of valproic acid analog for the treatment and prevention of migraine and affective illness
GB2367748A (en) Use of optically pure (R)- tofisopam for treating and preventing anxiety disorders and composition thereof
HK1086775A1 (en) Uses of fluorinated triazoles for treating affective or attention disorders
HK1047549A1 (en) Il6ril6 chimera for the treatment of neurodegeneraive diseases.
AU2001233955A1 (en) Diagnosis and treatment of bipolar affective disorder
BG103543A (en) The use of pramipexol in the treatment of the uneasy legs syndrome
MXPA04010816A (es) Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares.
ZA9711468B (en) New use of comt inhibitors
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
BR0206918A (pt) Uso de iloperidona
ZA200107138B (en) Use of fluorinated triazoles for treating pain and affective or attention disorders.
UA29506C2 (uk) Лікувально-косметичний засіб "фіто-пелоїд"

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20200227